Literature DB >> 33174114

Pneumocephalus in subthalamic deep brain stimulation for Parkinson's disease: a comparison of two different surgical techniques considering factors conditioning brain shift and target precision.

Massimo Piacentino1, Giacomo Beggio1, Oriela Rustemi1, Giampaolo Zambon1, Manuela Pilleri2, Fabio Raneri3.   

Abstract

BACKGROUND: Precise placement of electrodes in deep brain stimulation (DBS) may be influenced by brain shift caused by cerebrospinal fluid leaking or air inflow. We compared accuracy and treatment outcomes between a standard technique and one aiming at reducing brain shift.
METHODS: We retrospectively reviewed 46 patients (92 targets) treated with bilateral subthalamic-DBS for Parkinson's disease. The patients were divided into two groups: group A surgery was performed in supine position with standard burr hole, dural opening, fibrin glue and gelfoam plugging. Group B patients were operated in a semi-sitting position with direct dural puncture to reduce CSF loss. We analysed target deviation on head CT performed immediately after surgery and at 1 month merged with preoperative MRI planning. We recorded pneumocephalus volume, brain atrophy and target correction by intraoperative neurophysiology (ION).
RESULTS: In group A, the mean pneumocephalus volume was 10.55 cm3, mean brain volume 1116 cm3, mean target deviation 1.09 mm and ION corrected 70% of targets. In group B, mean pneumocephalus was 7.60 cm3 (p = 0.3048), mean brain volume 1132 cm3 (p = 0.6526), mean target deviation 0.64 mm (p = 0.0074) and ION corrected 50% of targets (p = 0.4886). Most leads' deviations realigned to the planned target after pneumocephalus reabsorbtion suggesting a deviation caused by displacement of anatomical structures due to brain shift. Definitive lead position was always decided with ION.
CONCLUSIONS: The modified DBS technique significantly reduced errors of electrode placement, though such difference was clinically irrelevant. ION corrected a high amount of trajectories in both groups (70% vs 50%). The choice of either strategy is acceptable.

Entities:  

Keywords:  Brain shift; Deep brain stimulation; Parkinson’s disease; Pneumocephalus

Mesh:

Year:  2020        PMID: 33174114     DOI: 10.1007/s00701-020-04635-9

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  10 in total

1.  The subthalamic nucleus in Parkinson's disease: somatotopic organization and physiological characteristics.

Authors:  M C Rodriguez-Oroz; M Rodriguez; J Guridi; K Mewes; V Chockkman; J Vitek; M R DeLong; J A Obeso
Journal:  Brain       Date:  2001-09       Impact factor: 13.501

2.  The physics of the cranial cavity, hydrocephalus and normal pressure hydrocephalus: mechanical interpretation and mathematical model.

Authors:  S Hakim; J G Venegas; J D Burton
Journal:  Surg Neurol       Date:  1976-03

3.  Asleep Deep Brain Stimulation Reduces Incidence of Intracranial Air during Electrode Implantation.

Authors:  Andrew L Ko; Philippe Magown; Alp Ozpinar; Vural Hamzaoglu; Kim J Burchiel
Journal:  Stereotact Funct Neurosurg       Date:  2018-05-30       Impact factor: 1.875

4.  Minimizing brain shift during functional neurosurgical procedures - a simple burr hole technique that can decrease CSF loss and intracranial air.

Authors:  V A Coenen; A Abdel-Rahman; J McMaster; N Bogod; C R Honey
Journal:  Cent Eur Neurosurg       Date:  2011-07-07

5.  Simultaneous bilateral stereotactic procedure for deep brain stimulation implants: a significant step for reducing operation time.

Authors:  Erich Talamoni Fonoff; Angelo Azevedo; Jairo Silva Dos Angelos; Raquel Chacon Ruiz Martinez; Jessie Navarro; Paul Rodrigo Reis; Miguel Ernesto San Martin Sepulveda; Rubens Gisbert Cury; Maria Gabriela Dos Santos Ghilardi; Manoel Jacobsen Teixeira; William Omar Contreras Lopez
Journal:  J Neurosurg       Date:  2015-12-18       Impact factor: 5.115

6.  Intracranial air correlates with preoperative cerebral atrophy and stereotactic error during bilateral STN DBS surgery for Parkinson's disease.

Authors:  Hooman Azmi; Andre Machado; Milind Deogaonkar; Ali Rezai
Journal:  Stereotact Funct Neurosurg       Date:  2011-07-21       Impact factor: 1.875

7.  Microelectrode recording revealing a somatotopic body map in the subthalamic nucleus in humans with Parkinson disease.

Authors:  Pantaleo Romanelli; Gary Heit; Bruce C Hill; Alli Kraus; Trevor Hastie; Helen M Brontë-Stewart
Journal:  J Neurosurg       Date:  2004-04       Impact factor: 5.115

8.  Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease.

Authors:  P Limousin; P Krack; P Pollak; A Benazzouz; C Ardouin; D Hoffmann; A L Benabid
Journal:  N Engl J Med       Date:  1998-10-15       Impact factor: 91.245

9.  Impact of brain shift on subcallosal cingulate deep brain stimulation.

Authors:  Ki Sueng Choi; Angela M Noecker; Patricio Riva-Posse; Justin K Rajendra; Robert E Gross; Helen S Mayberg; Cameron C McIntyre
Journal:  Brain Stimul       Date:  2017-12-06       Impact factor: 8.955

10.  Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease.

Authors:  Paul Krack; Alina Batir; Nadège Van Blercom; Stephan Chabardes; Valérie Fraix; Claire Ardouin; Adnan Koudsie; Patricia Dowsey Limousin; Abdelhamid Benazzouz; Jean François LeBas; Alim-Louis Benabid; Pierre Pollak
Journal:  N Engl J Med       Date:  2003-11-13       Impact factor: 91.245

  10 in total
  2 in total

1.  A Modified Dura Puncture Procedure to Reduce Brain Shift in Deep Brain Stimulation Surgery: One Institution's Experience.

Authors:  Yu-Xi Wu; Wei Xiang; Jia-Jing Wang; Xiao-Ming Liu; Dong-Ye Yi; Han Tian; Hong-Yang Zhao; Xiao-Bing Jiang; Peng Fu
Journal:  Front Neurol       Date:  2022-02-28       Impact factor: 4.003

Review 2.  A systematic review of brain morphometry related to deep brain stimulation outcome in Parkinson's disease.

Authors:  Fengting Wang; Yijie Lai; Yixin Pan; Hongyang Li; Qimin Liu; Bomin Sun
Journal:  NPJ Parkinsons Dis       Date:  2022-10-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.